Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.05 CHF
10.45 M CHF
157.63 M CHF
11.12 M
About BASILEA N
Sector
CEO
David Veitch
Headquarters
Allschwil
Website
Founded
2000
ISIN
CH0011432447
FIGI
BBG000BWPHB9
Basilea Pharmaceutica AG engages in the development and commercialization of pharmaceutical products. Its products include antifungals and antibiotics. The company was founded on October 17, 2000, and is headquartered in Allschwil, Switzerland.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of BSLN is 39.80 CHF — it has decreased by −0.63% in the past 24 hours. Watch BASILEA N stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange BASILEA N stocks are traded under the ticker BSLN.
BSLN stock has fallen by −5.81% compared to the previous week, the month change is a −11.67% fall, over the last year BASILEA N has showed a 10.86% increase.
We've gathered analysts' opinions on BASILEA N future price: according to them, BSLN price has a max estimate of 100.00 CHF and a min estimate of 52.00 CHF. Watch BSLN chart and read a more detailed BASILEA N stock forecast: see what analysts think of BASILEA N and suggest that you do with its stocks.
BSLN reached its all-time high on Mar 30, 2007 with the price of 284.75 CHF, and its all-time low was 28.55 CHF and was reached on Sep 15, 2011. View more price dynamics on BSLN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
BSLN stock is 2.16% volatile and has beta coefficient of 1.21. Track BASILEA N stock price on the chart and check out the list of the most volatile stocks — is BASILEA N there?
Today BASILEA N has the market capitalization of 484.85 M, it has decreased by −3.29% over the last week.
Yes, you can track BASILEA N financials in yearly and quarterly reports right on TradingView.
BASILEA N is going to release the next earnings report on Feb 18, 2025. Keep track of upcoming events with our Earnings Calendar.
BSLN earnings for the last half-year are 1.61 CHF per share, whereas the estimation was 1.17 CHF, resulting in a 37.61% surprise. The estimated earnings for the next half-year are 2.48 CHF per share. See more details about BASILEA N earnings.
BASILEA N revenue for the last half-year amounts to 76.30 M CHF, despite the estimated figure of 106.10 M CHF. In the next half-year revenue is expected to reach 125.93 M CHF.
BSLN net income for the last half-year is 20.74 M CHF, while the previous report showed −21.39 M CHF of net income which accounts for 196.95% change. Track more BASILEA N financial stats to get the full picture.
No, BSLN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 19, 2024, the company has 147.00 employees. See our rating of the largest employees — is BASILEA N on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BASILEA N EBITDA is −4.99 M CHF, and current EBITDA margin is 14.39%. See more stats in BASILEA N financial statements.
Like other stocks, BSLN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BASILEA N stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BASILEA N technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BASILEA N stock shows the strong sell signal. See more of BASILEA N technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.